HomePLUR • NASDAQ
add
Pluri Inc
Nakaraang pagsara
$3.60
Sakop ng araw
$3.56 - $3.62
Sakop ng taon
$2.82 - $7.13
Market cap
36.10M USD
Average na Volume
11.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 198.00K | 7.03% |
Gastos sa pagpapatakbo | 6.59M | 30.07% |
Net na kita | -6.54M | -121.35% |
Net profit margin | -3.30K | -106.81% |
Kita sa bawat share | — | — |
EBITDA | -6.38M | -30.44% |
Aktuwal na % ng binabayarang buwis | 0.12% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 12.48M | -41.43% |
Kabuuang asset | 30.60M | -0.86% |
Kabuuang sagutin | 39.81M | 17.85% |
Kabuuang equity | -9.21M | — |
Natitirang share | 10.05M | — |
Presyo para makapag-book | -2.47 | — |
Return on assets | -50.62% | — |
Return on capital | -59.88% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.54M | -121.35% |
Cash mula sa mga operasyon | -5.20M | -12.47% |
Cash mula sa pag-invest | 2.66M | -69.25% |
Cash mula sa financing | 2.84M | — |
Net change in cash | 257.00K | -93.69% |
Malayang cash flow | -3.23M | -10.93% |
Tungkol
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
CEO
Itinatag
May 11, 2001
Headquarters
Website
Mga Empleyado
135
